Juvenile chronic myelogenous leukemia: therapeutic trial with interferon alpha 2B.
Agarwal
B R
BR
Department of Pediatric Hematology and Oncology, B.J. Wadia Hospital for Children, Bombay.
Gulvady
A
A
Joshi
K
K
Khemani
S
S
Currimbhoy
Z E
ZE
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D017809:Fatal Outcome; D006801:Humans; D007223:Infant; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D011994:Recombinant Proteins
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins